Chemotherapy followed by low dose radiotherapy in childhood Hodgkin's disease: Retrospective analysis of results and prognostic factors

Radiation Oncology

Volumn 1, Issue 1, 2006, Pages

  Viani, Gustavo A ^a   Castilho, Marcus S ^a   Novaes, Paulo E ^a   Antonelli, Celia G ^a   Ferrigno, Robson ^a   Pellizzon, Cassio A ^a   Fogaroli, Ricardo C ^a   Conte, Maria A ^a   Salvajoli, Joao V ^a  

^a Department of Radiation Oncology Hospital do Câncer ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; CHILD; DRUG THERAPY; FEMALE; HODGKIN DISEASE; HUMAN; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PRESCHOOL CHILD; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DRUG THERAPY; FEMALE; HODGKIN DISEASE; HUMANS; MALE; PROGNOSIS; RADIOTHERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34248385301     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-1-38     Document Type: Article

References (34)

1. Chen MG Prosnitz LR Gonzalez-Serva A Fischer DB Results of radiotherapy in control of stage I and II non-Hodgkin's lymphoma Cancer 1979 43 1245-54 10.1002/ 1097-0142(197904)43:4<1245::AID-CNCR2820430412>3.0.CO;2-Z 445327
2. Connors JM Klimo P Fairey RN Voss N Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma Ann Intern Med 1987 107 25-30 3296898
3. Cabanillas F Bodey GP Freireich EJ Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histologic types Cancer 1980 46 2356-9 10.1002/ 1097-0142(19801201)46:11<2356::AID-CNCR2820461107>3.0.CO;2-X 7002279
4. Jones SE Miller TP Connors JM Long term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy J Clin Oncol 1989 7 1186-91 2671279
5. Miller TP Dahlberg S Cassady JR Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma N Engl J Med 1998 339 21-6 10.1056/ NEJM199807023390104 9647875
6. Hunger SP Link MP Donaldson SS ABVD/MOPP and low dose involved-field radiotherapy in pediatric Hodgkin's disease: The Stanford experience J Clin Oncol 1994 12 2160-2166 7523608
7. Hudson MM Greenwald C Thompson E Efficacy and toxicity of multiagent chemotherapy and low-dose involved- field radiotherapy in children and adolescents with Hodgkin's disease J Clin Oncol 1993 11 100-108 8418221
8. Hunger SP Link MP Donaldson SS ABVD/MOPP and low dose involved-field radiotherapy in pediatric Hodgkin's disease: The Stanford experience J Clin Oncol 1994 12 2160-2166 7523608
9. Jenkin D Doyle J Berry M Hodgkin's disease in children: Treatment with MOPP and low dose, extended field irradiation without laparotomy. Late results and toxicity Med Ped Oncol 1990 18 265-272
10. Oberlin O Leverger G Pacquement H Low dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: The experience of the French Society of Pediatric Oncology J Clin Oncol 1992 10 1602-1608 1383434
11. Schellong G Hörnig I Schwarze EW Risk factor adapted treatment of Hodgkin's lymphoma in childhood: Strategies and results of three consecutive multicenter studies in the Federal Republic of Germany New aspects in cancer research Diehl V, Pfreundschuh M, Loeffler M 1988 117 205-213
12. Schellong G Bramswig JH Hornig-Franz I Treatment of children with Hodgkin's disease: Results of the German Pediatric Oncology Group Ann Oncol 1992 3 Suppl.4 73-76 1450084
13. Vecchi V Pileri S Burnelli R Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age: An Italian (AIEOP) multicenter study on 215 patients Cancer 1993 72 2049-2057 10.1002/ 1097-0142(19930915)72:6<2049::AID-CNCR2820720642>3.0.CO;2-V 7689924
14. Canellos GP Horwich A Management of recurrent Hodgkin's disease, in Mauch PM, Armitage JO, Diehl V, et al (eds): Hodgkin's Disease Philadelphia, PA, Lippincott, Williams & Wilkins 1999 507-519
15. Phillips JK Spearing RL Davies JM VIM-D salvage chemotherapy in Hodgkin's disease Cancer Chemother Pharmacol 1990 27 161-163 10.1007/ BF00689103 2249334
16. Fairey AF Mead GM Jones HW CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy Ann Oncol 1993 4 857-860 8117605
17. Smith MR Khanuja PS Al-Katib A Continuous infusion ABDIC therapy for relapsed or refractory Hodgkin's disease Cancer 1994 73 1264-1269 10.1002/ 1097-0142(19940215)73:4<1264::AID-CNCR2820730422>3.0.CO;2-Q 7508818
18. Brusamolino E Orlandi E Canevari A Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease Ann Oncol 1994 5 427-432 7521204
19. Canellos GP Petroni GR Barcos M Etoposide, vinblastine, and doxorubicin: An active regimen for the treatment of Hodgkin's disease in relapse following MOPP J Clin Oncol 1995 13 2005-2011 7636541
20. Fermé C Bastion Y Lepage E The MINE regimen as intensive salvage chemotherapy for relapsed and refractory Hodgkin's disease Ann Oncol 1995 6 543-549 8573532
21. Aparicio J Segura A Garcera S ESHAP is an active regimen for relapsing Hodgkin's disease Ann Oncol 1999 10 593-595 10.1023/A:1026454831340 10416011
22. Josting A Rudolph C Reiser M Time - intensified dexamethasone/cisplatin/ cytarabine: An effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease Ann Oncol 2002 13 1628-1635 10.1093/annonc/mdf221 12377653
23. Colwill R Crump M Couture F Mini-BEAM as salvage therapy for relapsed refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation J Clin Oncol 1995 13 396-402 7844600
24. Schellong G Pediatric Hodgkin's disease: Treatment in the late 1990s Ann Oncol review 1998 9 suppl 5 115-119 10.1023/A:1008482728545
25. Shankar AG Ashley S Radford M Barrett A Wright D Pinkerton CR Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group J Clin Oncol 1997 15 2622-2630 9215833
26. Atra A Higgs E Capra M Elsworth A Imeson J Radford M ChlVPP chemotherapy in children with stage IV Hodgkin's disease: Results of the UKCCSG HD 8201 and HD 9201 studies Br J Haematol 2002 119 647-651 10.1046/ j.1365-2141.2002.03927.x 12437639
27. Baez F Ovampo E Conter V Flores A Gutierrez T Malta A Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua Ann Oncol 1997 8 247-250 10.1023/ A:1008200210674 9137793
28. Nachman JB Sposto R Herzog P Randomized comparison of low dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy J Clin Oncol 2002 20 3765-3771 10.1200/JCO.2002.12.007 12228196
29. Rühl U Albrecht M Dieckmann K Response-adapted radiotherapy in the treatment of pediatric Hodgkin's disease: An interim report at 5 years of the German GPOH-HD 95 trial Int J Radiat Oncol Biol Phys 2001 51 1209-1218 10.1016/S0360-3016(01)01798-9 11728679
30. Bhatia S Robison LL Oberlin O Greenberg M Bunin G Fossati-Bellani F Breast cancer and other second neoplasms after childhood Hodgkin's disease N Engl J Med 1996 334 745-751 10.1056/NEJM199603213341201 8592547
31. Bhatia S Yasui Y Robison LL Birch JM Bogue MK Diller L High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effect Study Group J Clin Oncol 2003 21 4386-4394 10.1200/JCO.2003.11.059 14645429
32. Smith RS Chen Q Hudson M Prognostic factors in pediatric Hodgkin's disease. [Abstract] Int J Radiat Oncol Biol Phys 2001 51 3 Suppl 1 119 10.1016/S0360-3016(01)02041-7
33. Friedmann AM Hudson MM Weinstein HJ Donaldson SS Kun L Tarbell NJ Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involvedfield radiation J Clin Oncol 2002 20 3088-3094 10.1200/ JCO.2002.03.051 12118022
34. Smith RS Chen Q Hudson MM Link MP Kun L Weinstein H Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy J Clin Oncol 2003 21 2026-2033 10.1200/JCO.2003.07.124 12743158